Raymond James stock holds close to 12-month high as investors eye Q3 2026 earnings
Published on 08/26/2026 at 22:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Raymond James Financial (US7547301090) stock is trading close to its recent 12-month high as of August 26, 2026, with shares recently quoted at $174.92 on the NYSE while investors wait for the next set of quarterly numbers. The upcoming Q3 2026 earnings date and related events later in August 2026 are drawing attention to how the diversified financial services group is managing margins and growth in its core businesses.
Q3 2026 earnings timing and expectations
According to a detailed financial calendar overview, Raymond James Financial has its Q3 2026 earnings release listed for late August 2026, with multiple related earnings presentations and an extraordinary general meeting clustered around August 26 and August 27, 2026. This calendar overview shows that a Q3 2026 results publication and investor presentations are scheduled on August 26 and August 27, 2026, underscoring how the coming days are pivotal for fresh guidance and an updated view on profitability trends.
For investors, this Q3 2026 update will be the first chance in several months to compare the company’s actual performance against the market’s expectations for revenue growth, net income and returns on capital. As of late August 2026, consensus forecasts compiled in the same calendar and estimates overview indicate continued growth in net income at the group level for the full fiscal 2026 year compared with fiscal 2025, supported by expectations for higher interest-sensitive revenues and resilient fee income.
Recent performance, consensus targets and valuation
Recent trading data place Raymond James Financial shares at $174.92 as of August 26, 2026, on the NYSE. One recent stock performance update notes that the stock opened at $174.92 on August 26, 2026, while another performance snapshot highlights that this level is close to a 12-month high of $182.73, framing the current price in the upper band of its one-year trading range. An additional performance review points out that the recent share price trades near that 12-month high of $182.73, which underlines how the stock already prices in meaningful earnings and balance sheet strength.
Consensus views compiled in these updates indicate that the average analyst price target for Raymond James Financial currently stands at $181.00 per share, compared with the recent $174.92 trading level, leaving an upside of $6.08 or roughly 3.5% from the latest quote to the consensus objective. The same consensus overview characterizes the stock’s rating as Hold, suggesting that analysts as a group see the shares as fairly valued with limited upside, despite the modest gap between the current market price and the $181.00 average target.
Market commentary also stresses that several institutional investors have been adjusting their positions in Raymond James Financial during recent quarters, with new stakes and increased holdings disclosed at recent prices around the mid-$170s. These flows indicate continued institutional engagement at valuations in line with the current quote, reinforcing how professional investors assess the risk-reward profile ahead of the Q3 2026 numbers and any potential changes to guidance for the remainder of fiscal 2026 and into fiscal 2027.
Fundamental backdrop and historical context
A broader fundamental snapshot from a detailed estimates and historical results overview shows that Raymond James Financial has delivered steadily rising net income over recent fiscal years. In that overview, net income for fiscal 2023 is reported at $1,733 million and for fiscal 2024 at $2,063 million, representing an increase of $330 million or 19.0% year over year. The same document further indicates that net income reached $2,130 million for fiscal 2025, which is $67 million or 3.2% higher than in fiscal 2024, highlighting a pattern of continued profitability expansion even as growth rates have moderated.
These figures serve as historical context going into the Q3 2026 announcement, showing that the company has grown its net income from $1,733 million in fiscal 2023 to $2,130 million in fiscal 2025, a cumulative increase of $397 million. While the upcoming Q3 2026 release will update investors on the trajectory for fiscal 2026 and beyond, the historical data underscore a track record of improving earnings in recent years, which helps explain why the share price has moved toward the top end of its 12-month range.
The same overview also sets out EBITDA trends for recent fiscal years, with EBITDA for fiscal 2023 listed at $2,577 million and for fiscal 2024 at $2,867 million, representing an increase of $290 million or 11.3%. This expansion in EBITDA over those two fiscal years illustrates how Raymond James Financial has managed to grow operating earnings while navigating shifts in interest rates, client activity levels and market conditions. Investors will look to Q3 2026 to see whether that operating momentum has carried into the current fiscal year and whether margins remain resilient in the face of any changes in the revenue mix.
Institutional activity and risk considerations
Several recent filings and portfolio updates highlight that institutional investors have been active in Raymond James Financial shares at current levels. One recent report describes a purchase involving 9,242,552 shares of Raymond James Financial, while other portfolio updates discuss smaller but notable positions including a $1.49 million investment and another stake valued at $26.82 million disclosed at recent prices. These flows demonstrate that both large and mid-sized institutional investors are committing capital at valuations close to the current $174.92 share price, providing a measure of support for the stock in the market.
From a risk perspective, the consensus Hold rating and modest $181.00 price target suggest that analysts see limited valuation headroom unless upcoming results surprise to the upside. With the stock already trading near its 12-month high of $182.73, any disappointment on Q3 2026 earnings, net new asset growth or margin trends could prompt a reassessment of that valuation. Conversely, if the company reports stronger-than-expected growth in key segments, increased net income versus prior-year quarters, or updated guidance that points to higher returns, there is scope for the shares to re-test and potentially exceed the 12-month high, given the current gap between the market price and historical performance metrics.
Wealth management and capital markets services
Raymond James Financial generates the bulk of its business from a mix of wealth management, institutional services and capital markets activities, providing financial planning, investment management and advisory services to individual and institutional clients. The company’s full profile describes it as a diversified financial services firm headquartered in St. Petersburg, Florida, with operations that include private client services, asset management, investment banking and related offerings, positioning it across multiple revenue streams that respond differently to interest rate cycles and market volatility.
In wealth management, Raymond James Financial supports financial advisors and their clients with brokerage accounts, managed portfolios and retirement planning solutions, a segment that benefits from both fee-based assets and transaction-related income. In capital markets and institutional services, the firm provides research, trading and investment banking capabilities, which can drive fees from underwriting, advisory mandates and other structured transactions. This diversified business mix means that the Q3 2026 results will be evaluated not only on headline revenue and net income, but also on segment-level trends such as changes in assets under administration, advisory fee growth and the health of the investment banking pipeline.
Stock level and as-of reference
Raymond James stock currently trades on the NYSE under the ticker RJF, with a recent quote of $174.92 as of August 26, 2026, during regular US trading hours, based on recent market data snapshots. With the 12-month high identified at $182.73 and the consensus price target at $181.00, the shares are positioned close to both their historical one-year peak and the average analyst objective, underlining how the forthcoming Q3 2026 earnings release and any updated guidance could be decisive in setting the next direction for the stock.
Fact box
Company: Raymond James Financial, Inc.
ISIN: US7547301090
Ticker: RJF
Exchange: NYSE
Price (as of August 26, 2026): $174.92 USD
Market cap: not specified in available data
Sector / Industry: Financial services / Diversified financials
Index membership: not specified in available data
